CCO Treatment Updates

Forging Partnerships in the Management of Hepatocellular Carcinoma: Multidisciplinary Strategies to Provide Continuity of Care

Module

Forging Partnerships in the Management of Hepatocellular Carcinoma: Multidisciplinary Strategies to Provide Continuity of Care

Program Directors: Luigi Bolondi, MD, Jorge A. Marrero, MD, MS

Faculty:

Adrian M. Di Bisceglie, MD, FACPJean-Francois Geschwind, MD
  • Adrian M. Di Bisceglie, MD, FACP
  • Jean-Francois Geschwind, MD

CME CREDIT INFORMATION

Release Date: 11/07/08

Expiration Date: 11/06/09


Physicians: maximum of 1.25 AMA PRA Category 1 Credits™

Status: Please log in to view status
Begin the CCO Slideset

Luigi Bolondi, MD, and other expert CCO faculty members review standard therapies and explore emerging strategies for the clinical management of patients with hepatocellular carcinoma, particularly those with unresectable or advanced disease.

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Discuss the importance of liver function in treating HCC patients
  • Summarize evidence-based data and optimal adverse event management for approved targeted agents in treating HCC
  • Describe novel agents currently under clinical investigation for HCC
  • Summarize patient selection criteria for regional therapy such as transcatheter arterial chemoembolization
  • Discuss strategies to optimize continuity of care for patients with HCC

Forging Partnerships in the Management of Hepatocellular Carcinoma: Multidisciplinary Strategies to Provide Continuity of Care


Luigi Bolondi, MD, and other expert CCO faculty members review standard therapies and explore emerging strategies for the clinical management of patients with hepatocellular carcinoma, particularly those with unresectable or advanced disease.


Format: Microsoft PowerPoint (.ppt) | File size: 2.79 MB


Disclaimer: The materials published on the Clinical Care Options Web site reflect the views of the reviewers or authors of the CCO material, not those of Clinical Care Options, LLC, the CME provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.

Jointly sponsored by Postgraduate Institute for Medicine and Clinical Care Options, LLC.

Contact Info

Educational grants provided by

Educational grants support only the CME-certified components of this program.